rs8135963
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_024105.4(ALG12):āc.885A>Gā(p.Ala295Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 1,613,820 control chromosomes in the GnomAD database, including 59,745 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.36 ( 13919 hom., cov: 32)
Exomes š: 0.23 ( 45826 hom. )
Consequence
ALG12
NM_024105.4 synonymous
NM_024105.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.39
Genes affected
ALG12 (HGNC:19358): (ALG12 alpha-1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 22 family. The encoded protein catalyzes the addition of the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. Mutations in this gene have been associated with congenital disorder of glycosylation type Ig (CDG-Ig)characterized by abnormal N-glycosylation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 22-49907828-T-C is Benign according to our data. Variant chr22-49907828-T-C is described in ClinVar as [Benign]. Clinvar id is 96102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-49907828-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-5.39 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG12 | NM_024105.4 | c.885A>G | p.Ala295Ala | synonymous_variant | 7/10 | ENST00000330817.11 | NP_077010.1 | |
ALG12 | XM_017028936.2 | c.885A>G | p.Ala295Ala | synonymous_variant | 7/10 | XP_016884425.1 | ||
ALG12 | XM_017028937.2 | c.885A>G | p.Ala295Ala | synonymous_variant | 7/11 | XP_016884426.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG12 | ENST00000330817.11 | c.885A>G | p.Ala295Ala | synonymous_variant | 7/10 | 1 | NM_024105.4 | ENSP00000333813.5 | ||
ALG12 | ENST00000486602.1 | c.90A>G | p.Ala30Ala | synonymous_variant | 1/4 | 3 | ENSP00000420630.1 | |||
ALG12 | ENST00000492791.1 | n.414A>G | non_coding_transcript_exon_variant | 3/6 | 3 | ENSP00000417387.1 |
Frequencies
GnomAD3 genomes AF: 0.358 AC: 54348AN: 151950Hom.: 13859 Cov.: 32
GnomAD3 genomes
AF:
AC:
54348
AN:
151950
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.256 AC: 64213AN: 251256Hom.: 11252 AF XY: 0.258 AC XY: 35082AN XY: 135848
GnomAD3 exomes
AF:
AC:
64213
AN:
251256
Hom.:
AF XY:
AC XY:
35082
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.229 AC: 334278AN: 1461752Hom.: 45826 Cov.: 37 AF XY: 0.234 AC XY: 170123AN XY: 727166
GnomAD4 exome
AF:
AC:
334278
AN:
1461752
Hom.:
Cov.:
37
AF XY:
AC XY:
170123
AN XY:
727166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.358 AC: 54463AN: 152068Hom.: 13919 Cov.: 32 AF XY: 0.354 AC XY: 26284AN XY: 74328
GnomAD4 genome
AF:
AC:
54463
AN:
152068
Hom.:
Cov.:
32
AF XY:
AC XY:
26284
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1152
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 25, 2012 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
ALG12-congenital disorder of glycosylation Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at